Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1/2 1

Status

Recruiting 3Active not recruiting 3Terminated 2Completed 2Not yet recruiting 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 13Dermatologic 11Head & Neck 6Tumor-Agnostic 3Genitourinary 3Gastrointestinal 3Sarcoma 2Breast 2Plasma cell 1Gynecologic 1CNS 1

Conditions

Neoplasms 2Neoplasm Metastasis 1Carcinoma, Squamous Cell 1Carcinoma 1

Interventions

pembrolizumab 17Specimen Handling 9Magnetic Resonance Spectroscopy 9Bevacizumab 8Paclitaxel 7Biopsy 7Nivolumab 6atezolizumab 5Surveys and Questionnaires 4Standard of Care 4Radiosurgery 4Practice Guidelines as Topic 4Pemetrexed 4Oxaliplatin 4Cyclophosphamide 4Carboplatin 4osimertinib 3niraparib 3durvalumab 3cemiplimab 3avelumab 3Radiotherapy 3Radiation 3Leucovorin 3Irinotecan 3Ipilimumab 3Interviews as Topic 3Fluorouracil 3trastuzumab deruxtecan 2trametinib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Active not recruiting × cemiplimab × Tumor-Agnostic × Clear all
NCT04706715 2025-05-31

LAG3 PET Imaging in Advanced Solid Tumors

University Medical Center Groningen

Phase 1/2 Active not recruiting
41 enrolled
Tumor-Agnostic

Neoplasm Metastasis, Neoplasms

NCT04050436 2025-01-27

CERPASS

Replimune, Inc.

Phase 2 Active not recruiting
231 enrolled
Tumor-Agnostic

Carcinoma, Carcinoma, Squamous Cell

NCT05878288 2024-11-21

DISCERN

Peter MacCallum Cancer Centre, Australia

Phase 2 Active not recruiting
11 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡